Standardization of IMT Dosage (UTIT) in Mechanical Ventilation. (UTIT-IMT)
Standardization of Inspiratory Muscle Training Dose in Mechanically Ventilated Patients: A Randomized Clinical Trial Using the Total Inspiratory Work Unit (UTIT).
Respiratory muscle weakness prolongs mechanical ventilation (MV) and delays weaning. Currently, there is no standardized dosage for Inspiratory Muscle Training (IMT) in the ICU. This study aims to define an optimal IMT dosage using a new metric called "Total Inspiratory Work Unit" (UTIT), which integrates intensity, repetition, and frequency.
The study compares three daily dosage regimens (1,000 UTIT, 2,000 UTIT, and 3,000 UTIT) adjusted daily based on the patient's Negative Inspiratory Force (NIF). The goal is to determine the optimal dose-response relationship for improving inspiratory muscle strength (PiMax) and reducing the duration of mechanical ventilation.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a randomized clinical trial conducted at Hospital H+ Querétaro. Eligible intubated patients will be assigned to one of three intervention groups differing in the daily volume of inspiratory work.
The "Total Inspiratory Work Unit" (UTIT) is defined as: UTIT = (Target NIF %) x (Number of Breaths per Session) x (Number of Sessions per Day).
Intensity is adjusted daily to maintain the target UTIT dose. The study utilizes a threshold loading device (POWERbreathe K5) with real-time feedback. Safety parameters (SpO2, HR, FR, MAP) are monitored continuously during sessions. The intervention continues until successful weaning, extubation, ICU discharge, or death.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Querétaro
-
Querétaro City, Querétaro, Mexiko, 76000
- Hospital H+ Querétaro, Santiago de Querétaro, Querétaro
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Adult patients (>18 years of age) admitted to the Intensive Care Unit (ICU).
- Invasive mechanical ventilation support for more than 48-72 hours.
- Hemodynamic stability (defined as absence of vasopressors or receiving stable doses).
- Adequate oxygenation and ventilatory parameters: PEEP < 10 cmH2O, FiO2 < 0.6, and PaO2/FiO2 ratio > 150-200.
- Ability to cooperate with instructions or absence of deep sedation.
Exclusion Criteria:
- Pre-existing neuromuscular pathology directly affecting respiratory muscles.
- Severe thoracic trauma or recent thoracic surgery.
- Unresolved pneumothorax or bronchopleural fistula.
- Severe hemodynamic instability or severe cardiac arrhythmias.
- Level of sedation that prevents active participation in sessions.
- Pregnancy
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Low Dose Group (1,000 UTIT)
Participants receive a daily IMT dosage of 1,000 Total Inspiratory Work Units (UTIT). Intensity: 30% of the patient's baseline Negative Inspiratory Force (NIF). Repetitions: 30 breaths per session. Frequency: 1 session per day |
Respiratory rehabilitation training using a specific threshold loading device (POWERbreathe K5) with real-time feedback.
The intervention aims to strengthen inspiratory muscles (diaphragm and intercostals).
The daily dosage is calculated using the Total Inspiratory Work Unit (UTIT) formula, adjusted daily based on the patient's Negative Inspiratory Force (NIF).
|
|
Experimentell: Intermediate Dose Group (2,000 UTIT)
Participants receive a daily IMT dosage of 2,000 Total Inspiratory Work Units (UTIT). Intensity: 50% of the patient's baseline Negative Inspiratory Force (NIF). Repetitions: 60 breaths per session. Frequency: 2 sessions per day. |
Respiratory rehabilitation training using a specific threshold loading device (POWERbreathe K5) with real-time feedback.
The intervention aims to strengthen inspiratory muscles (diaphragm and intercostals).
The daily dosage is calculated using the Total Inspiratory Work Unit (UTIT) formula, adjusted daily based on the patient's Negative Inspiratory Force (NIF).
|
|
Experimentell: High Dose Group (3,000 UTIT)
Participants receive a daily IMT dosage of 3,000 Total Inspiratory Work Units (UTIT). Intensity: 80% of the patient's baseline Negative Inspiratory Force (NIF). Repetitions: 60 breaths per session. Frequency: 3 sessions per day. |
Respiratory rehabilitation training using a specific threshold loading device (POWERbreathe K5) with real-time feedback.
The intervention aims to strengthen inspiratory muscles (diaphragm and intercostals).
The daily dosage is calculated using the Total Inspiratory Work Unit (UTIT) formula, adjusted daily based on the patient's Negative Inspiratory Force (NIF).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Maximal Inspiratory Pressure (Pimax)
Tidsram: From baseline (study entry) up to successful weaning, extubation, or ICU discharge (up to 30 days).
|
Change in maximal inspiratory pressure measured in cmH₂O using the POWERbreathe K5 device to evaluate inspiratory muscle strength from baseline to the end of the intervention.
|
From baseline (study entry) up to successful weaning, extubation, or ICU discharge (up to 30 days).
|
|
Total Duration of Mechanical Ventilation
Tidsram: From the initiation of mechanical ventilation until successful extubation or ICU discharge (up to 30 days)
|
Total number of consecutive days a patient requires invasive mechanical ventilation support via endotracheal tube.
|
From the initiation of mechanical ventilation until successful extubation or ICU discharge (up to 30 days)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Duration of the Weaning Process
Tidsram: From the start of the weaning process up to successful extubation (up to 30 days)
|
Number of days from the first spontaneous breathing trial (SBT) or initiation of weaning protocol until successful extubation
|
From the start of the weaning process up to successful extubation (up to 30 days)
|
|
Reintubation Rate Within 72 Hours
Tidsram: Within 72 hours post-extubation
|
Percentage of patients who require reintubation within 72 hours following initial planned extubation.
|
Within 72 hours post-extubation
|
|
Length of Stay in Intensive Care Unit (ICU)
Tidsram: From study enrollment until ICU discharge (up to 30 days).
|
Total number of days the patient remains admitted to the ICU.
|
From study enrollment until ICU discharge (up to 30 days).
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- CEI2025-12V1
- REHAB-25-1 (Annan identifierare: CEI2025-12V1)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .